Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN109384794A reveals protic acid catalyzed route. High yield, green chemistry. Reliable supplier for scale-up.
Patent CN107266414A reveals copper-catalyzed C-H amination for aminomethyl thiophenes. This method offers significant supply chain and cost advantages for pharmaceutical intermediates manufacturing.
Patent CN116640146A details a Pd-catalyzed one-pot synthesis. Offers high purity, scalable production, and cost reduction for pharmaceutical intermediate manufacturing.
Patent CN114539198B details a novel Pd-catalyzed route for chroman amides. Offers cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN100389877C details a novel PEG-supported ruthenium catalyst enabling ambient pressure asymmetric hydrogenation, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel iodine-promoted synthesis of trifluoromethyl-triazoles via patent CN113105402B. A cost-effective, scalable route for high-purity pharmaceutical intermediates without heavy metals.
Patent CN114195711B details a novel Pd-catalyzed carbonylation route. Offers safer processing and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN117736120A reveals a metal-free synthesis route for β-fluoroalkyl-β-aminovinyl ketones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN119320392A details a green catalytic route for Rucaparib. This report analyzes cost reduction in API manufacturing and supply chain reliability for procurement teams.
Patent CN113896648B reveals nickel-catalyzed synthesis avoiding toxic CO gas. Delivers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN115215814A details a novel Rh-catalyzed C-H activation route to isoxazolidines, offering mild conditions and broad substrate scope for reliable pharmaceutical intermediate supply.
Novel isoindolinone-derived unsaturated imine synthesis via binaphthyl phosphoric acid. Delivers high yield, scalable production, and cost advantages for pharmaceutical supply chains.
Patent CN105152946B reveals ionic liquid catalysis for o-aminobenzaldehyde. High yield, mild conditions, supply chain stability. Ideal for pharmaceutical intermediate manufacturing.
Patent CN104529895B reveals a one-step aqueous synthesis for isoquinoline derivatives. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel synthesis method offers high enantioselectivity and significant cost reduction for chiral catalyst manufacturing supply chains globally ensuring reliable pharmaceutical intermediates
Novel Pd-catalyzed carbonylation method offers high yields and broad substrate scope for cost-effective API intermediate manufacturing.
Novel one-pot synthesis improves yield and purity for bazedoxifene intermediate. Reduces cost and simplifies supply chain for pharmaceutical partners globally.
Novel CuCl-catalyzed method for 1,2,4-triazolyl arylamines. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN108690007B reveals a room-temperature ionic liquid method for ortho-cyanation, offering safer pharma intermediate manufacturing and reduced waste.
Patent CN113121462B reveals a safe, metal-free synthesis for 5-trifluoromethyl-1,2,3-triazoles, offering cost reduction and scalability for pharma intermediates.